Introduction to Focus on Fabry Nephropathy: Biomarkers, Progression, and Disease Severity

被引：2
|
作者：
Warnock, David G. [1 ]
Remuzzi, Giuseppe [2 ,3 ]
Brenner, Barry M. [4 ]
Levin, Adeera [5 ]
Wanner, Christoph [6 ]
机构：
[1] Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[2] Mario Negri Inst Pharmacol Res, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy
[3] Azienda Osped Osped Riuniti Bergamo, Nephrol Unit, Bergamo, Italy
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[6] Univ Wurzburg, Dept Med, Wurzburg, Germany
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
关键词：
D O I：
10.2215/CJN.08191109
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [1] Biomarkers of Fabry Disease Nephropathy
    Schiffmann, Raphael
    Waldek, Stephen
    Benigni, Ariela
    Auray-Blais, Christiane
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02): : 360 - 364
  • [2] Tubular dysfunction biomarkers in Fabry disease: better than albuminuria to identify patients at risk of nephropathy progression
    Aguiar, Patricio
    Azevedo, Olga
    Pinto, Rui
    Marino, Jacira
    Cardoso, Carlos
    Ducla Soares, Jose Luis
    Hughes, Derralynn
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S16 - S17
  • [3] Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression
    Alonso-Nunez, Adrian
    Perez-Marquez, Tania
    Alves-Villar, Marta
    Fernandez-Pereira, Carlos
    Fernandez-Martin, Julian
    Rivera-Gallego, Alberto
    Melcon-Crespo, Cristina
    San Millan-Tejado, Beatriz
    Ruz-Zafra, Aurora
    Garofano-Lopez, Remedios
    Sanchez-Martinez, Rosario
    Garcia-Paya, Elena
    Lopez-Mendoza, Manuel
    Martin-Suarez, Ignacio
    Ortolano, Saida
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [4] A PANEL OF BIOMARKERS FOR THE PREDICTION OF DISEASE PROGRESSION IN IGA NEPHROPATHY
    Faria, Bernardo
    Henriques, Carla
    Matos, Ana C.
    Daha, Mohamed R.
    Pestana, Manuel
    Seelen, Marc
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 187 - 188
  • [5] Blood and urine biomarkers of disease progression in IgA nephropathy
    Duan, Zhi-Yu
    Zhang, Chun
    Chen, Xiang-Mei
    Cai, Guang-Yan
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [6] Fabry nephropathy: a search for urinary biomarkers
    Mlinsek, T.
    Levstek, T.
    Holcar, M.
    Goricar, K.
    Lenassi, M.
    Dolzan, V.
    Vujkovac, B.
    Podkrajsek, K. Trebusak
    FEBS OPEN BIO, 2021, 11 : 331 - 331
  • [7] Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy
    Fall, Brent
    Scott, C. Ronald
    Mauer, Michael
    Shankland, Stuart
    Pippin, Jeffrey
    Jefferson, Jonathan A.
    Wallace, Eric
    Warnock, David
    Najafian, Behzad
    PLOS ONE, 2016, 11 (12):
  • [8] Direct Correlation between Age at Diagnosis and Severity of Nephropathy in Fabry Disease Patients
    Jaurretche, Sebastian P. A.
    Antongiovanni, Norberto
    Perretta, Fernando
    INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (06) : 398 - 401
  • [9] Biomarkers of Fabry Nephropathy: Review and Future Perspective
    Levstek, Tina
    Vujkovac, Bojan
    Trebusak Podkrajsek, Katarina
    GENES, 2020, 11 (09) : 1 - 19
  • [10] Early Biomarkers of Fabry Nephropathy: A Review of the Literature
    Riccio, Eleonora
    Sabbatini, Massimo
    Capuano, Ivana
    Pisani, Antonio
    NEPHRON, 2019, 143 (04) : 274 - 281
12345